H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.

智通财经APP获悉，丹麦制药巨头Lundbeck表示将以26亿美元的股权价值收购Longboard Pharmaceuticals ...

Longboard Pharmaceuticals Inc.的股价已达到令人印象深刻的里程碑，创下58.92美元的历史新高。这一峰值反映了投资者信心的显著增强，从公司673.36%的一年涨幅可见一斑。制药行业一直密切关注Longboard ...

周一，尽管目标价从45美元上调至60美元，B.Riley分析师仍将Longboard Pharmaceuticals Inc (NASDAQ:LBPH)的评级从买入下调至中性。这一调整是在Longboard宣布与Lundbeck达成约26亿美元的收购协议后做出的，收购价格相当于每股60美元。这一收购价格较Longboard截至2024年9月30日的30天成交量加权平均股价溢价77%。 Longbo ...

两家公司周一表示，Lundbeck将以每股60美元的现金收购Longboard，较Longboard上周五38.90美元的收盘价溢价54%。此外，两家公司表示，该交易预计于今年年底完成，扣除Longboard现金后的价值约为25亿美元。

Pharmaceutical company Lundbeck will acquire Nasdaq-listed Longboard Pharmaceutical in a $2.6 billion deal, the two companies ...

Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious ...

The longboarding event in Abu Dhabi certainly had its moments. But, holding an event in this part of the world comes with ...

H. Lundbeck A/S is to acquire Longboard Pharmaceuticals Inc. in an all-cash deal valuing the epilepsy specialist at $2.6 billion. The agreed price of $60 per share is a 54% premium to the closing ...

Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share ...

Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the ...

The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion ...